Skip to main content
Clinical Trials/NCT01580956
NCT01580956
Completed
Phase 3

Evaluation a New Ventilatory Modes: VARIABLE-PSV: a Randomized Controlled Cross-over Study: the " VARIABLE-PSV" Study

University Hospital, Montpellier1 site in 1 country20 target enrollmentApril 2012

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Acute Respiratory Failure
Sponsor
University Hospital, Montpellier
Enrollment
20
Locations
1
Primary Endpoint
Oxygenation in each ventilatory mode
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Variable PSV is a new ventilatory mode which delivered a pressure support "variable" from 0 to 100% variation of the set PSV level.This study aimed to compare the ventilatory behavior, sleep quality and gas exchange between VARIABLE (or Noisy)-PSV and "standard" (or fixed)-PSV during the weaning phase of critically ill patients who required mechanical ventilation.

Detailed Description

Twenty patients will be enrolled. They will be ventilated withVARIABLE-PSV and STANDARD-PSV: for 24 h each in a randomized crossover order. The ventilatory parameters, ventilator/patient asynchrony, gas exchange effects, sleep quality and ventilatory comfort produced by the two ventilation modes will be compared. Before randomisation, a sequence of VARIABLE-PSV will be performed with different level of variation setting to better define the future behavior of the patient under this mode during the 24 h of Variable-PSV.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
August 2012
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ventilation planned for more than 48 h
  • patient alert and calm corresponding to a Richmond Agitation-Sedation Scale (RASS) between -2 and 0
  • Age \> or equal 18
  • Surrogate decision maker's consent

Exclusion Criteria

  • Clinical instability for any reason.
  • Life support withdrawal code
  • Patient under tutelage
  • Pregnancy
  • No French health insurance

Outcomes

Primary Outcomes

Oxygenation in each ventilatory mode

Time Frame: after 24h of mechanical ventilation in each mode

We will performed arterial blood gases and oxygenation wil be evaluated by the PaO2/FiO2 ration.

Secondary Outcomes

  • Ventilatory comfort(during 24h in each mode)
  • Feasibility(during the 24 hours)
  • Patient/ventilator asynchronism(during the 24 hours)
  • Ventilatory effects(during the 24 hours)
  • Sleep quality(after the 24 hours)

Study Sites (1)

Loading locations...

Similar Trials